Cargando…

Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles

The pure alpha emitter (148)Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to present an...

Descripción completa

Detalles Bibliográficos
Autores principales: Rääf, C., Barkauskas, V., Eriksson Stenström, K., Bernhardsson, C., Pettersson, H. B. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736586/
https://www.ncbi.nlm.nih.gov/pubmed/33318497
http://dx.doi.org/10.1038/s41598-020-77718-3
_version_ 1783622795358371840
author Rääf, C.
Barkauskas, V.
Eriksson Stenström, K.
Bernhardsson, C.
Pettersson, H. B. L.
author_facet Rääf, C.
Barkauskas, V.
Eriksson Stenström, K.
Bernhardsson, C.
Pettersson, H. B. L.
author_sort Rääf, C.
collection PubMed
description The pure alpha emitter (148)Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to present an approach to indirectly estimate the whole-body burden of (148)Gd and the associated committed effective dose in exposed humans, by means of high-resolution gamma spectrometry of the gamma-emitting radiogadolinium isotopes (146)Gd and (153)Gd that are accompanied by (148)Gd generated from the operation of the tungsten target. Theoretical minimum detectable whole-body activity (MDA) and associated internal doses from (148)Gd are calculated using a combination of existing biokinetic models and recent computer simulation studies on the generated isotope ratios of (146)Gd/(148)Gd and (153)Gd/(148)Gd in the ESS target. Of the two gamma-emitting gadolinium isotopes, (146)Gd is initially the most sensitive indicator of the presence of (148)Gd if whole-body counting is performed within a month after the release, using the twin photo peaks of (146)Gd centered at 115.4 keV (MDA < 1 Bq for ingested (148)Gd, and < 25 Bq for inhaled (148)Gd). The corresponding minimum detectable committed effective doses will be less than 1 µSv for ingested (148)Gd, but substantially higher for inhaled (148)Gd (up to 0.3 mSv), depending on operation time of the target prior to the release. However, a few months after an atmospheric release, (153)Gd becomes a much more sensitive indicator of body burdens of (148)Gd, with a minimum detectable committed effective doses ranging from 18 to 77 µSv for chronic ingestion and between 0.65 to 2.7 mSv for acute inhalation in connection to the release. The main issue with this indirect method for (148)Gd internal dose estimation, is whether the primary photon peaks from (146) and (153)Gd can be detected undisturbed. Preliminary simulations show that nuclides such as (182)Ta may potentially create perturbations that could impair this evaluation method, and which impact needs to be further studied in future safety assessments of accidental target releases.
format Online
Article
Text
id pubmed-7736586
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77365862020-12-15 Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles Rääf, C. Barkauskas, V. Eriksson Stenström, K. Bernhardsson, C. Pettersson, H. B. L. Sci Rep Article The pure alpha emitter (148)Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to present an approach to indirectly estimate the whole-body burden of (148)Gd and the associated committed effective dose in exposed humans, by means of high-resolution gamma spectrometry of the gamma-emitting radiogadolinium isotopes (146)Gd and (153)Gd that are accompanied by (148)Gd generated from the operation of the tungsten target. Theoretical minimum detectable whole-body activity (MDA) and associated internal doses from (148)Gd are calculated using a combination of existing biokinetic models and recent computer simulation studies on the generated isotope ratios of (146)Gd/(148)Gd and (153)Gd/(148)Gd in the ESS target. Of the two gamma-emitting gadolinium isotopes, (146)Gd is initially the most sensitive indicator of the presence of (148)Gd if whole-body counting is performed within a month after the release, using the twin photo peaks of (146)Gd centered at 115.4 keV (MDA < 1 Bq for ingested (148)Gd, and < 25 Bq for inhaled (148)Gd). The corresponding minimum detectable committed effective doses will be less than 1 µSv for ingested (148)Gd, but substantially higher for inhaled (148)Gd (up to 0.3 mSv), depending on operation time of the target prior to the release. However, a few months after an atmospheric release, (153)Gd becomes a much more sensitive indicator of body burdens of (148)Gd, with a minimum detectable committed effective doses ranging from 18 to 77 µSv for chronic ingestion and between 0.65 to 2.7 mSv for acute inhalation in connection to the release. The main issue with this indirect method for (148)Gd internal dose estimation, is whether the primary photon peaks from (146) and (153)Gd can be detected undisturbed. Preliminary simulations show that nuclides such as (182)Ta may potentially create perturbations that could impair this evaluation method, and which impact needs to be further studied in future safety assessments of accidental target releases. Nature Publishing Group UK 2020-12-14 /pmc/articles/PMC7736586/ /pubmed/33318497 http://dx.doi.org/10.1038/s41598-020-77718-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rääf, C.
Barkauskas, V.
Eriksson Stenström, K.
Bernhardsson, C.
Pettersson, H. B. L.
Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title_full Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title_fullStr Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title_full_unstemmed Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title_short Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
title_sort internal dose assessment of (148)gd using isotope ratios of gamma-emitting (146)gd or (153)gd in accidently released spallation target particles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736586/
https://www.ncbi.nlm.nih.gov/pubmed/33318497
http://dx.doi.org/10.1038/s41598-020-77718-3
work_keys_str_mv AT raafc internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT barkauskasv internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT erikssonstenstromk internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT bernhardssonc internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT petterssonhbl internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles